# Combining Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Large-vessel Ischemic Stroke

> **NCT06360120** · PHASE3 · RECRUITING · sponsor: **Kafrelsheikh University** · enrollment: 600 (estimated)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** Atorvastatin 40 Mg Oral Tablet
- **DRUG:** Rosuvastatin 20mg
- **DRUG:** Clopidogrel 75 Mg Oral Tablet
- **DRUG:** Clopidogrel 75 Mg Oral Tablet

## Key facts

- **NCT ID:** NCT06360120
- **Lead sponsor:** Kafrelsheikh University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-10
- **Primary completion:** 2025-09-10
- **Final completion:** 2025-10-01
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2025-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06360120

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06360120, "Combining Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Large-vessel Ischemic Stroke". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT06360120. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*